Gut Clinic raises seed round
Gut Clinic closed a ₹9 crore (about $1M) seed round from 15+ investors to scale its gut and metabolic health platform. The raise comes as the gut‑health market shifts toward science‑backed, ingredient‑specific products and digital care. (medicalbuyer.co.in) (foodnavigator.com)
Founded in 2024 by Dr. Akshat Kumar, Gut Clinic’s founder is a US‑certified physician with a Wharton MBA and a background leading McKinsey’s global clinical operations practice. (smestreet.in) The company’s senior leadership includes Dr. Manav Wadhawan as Chief Strategy and Medical Officer, and Gut Clinic has listed senior clinicians such as Prof. Nageshwar Reddy and Dr. Suresh Chari in its clinical network. (gutclinic.co) Gut Clinic currently operates in the Delhi NCR region and has announced plans to expand into Chandigarh, Punjab and other parts of northern India with a medium‑term target of establishing more than 20 centres. (outlookbusiness.com) Its care model is outpatient‑first with day‑care and hospital‑embedded centres, offering consultations, endoscopies, colonoscopies, advanced gastrointestinal diagnostics and clinical nutrition services. (entrackr.com) Company statements say the recent capital will be allocated to establish new centres, strengthen clinical systems and broaden diagnostic capabilities to support protocol‑driven management of chronic gastro, liver and metabolic conditions outside acute hospital settings. (indianstartupnews.com) Gut Clinic’s public materials cite market research that about 70 million Indians suffer lifestyle‑linked digestive and metabolic disorders and position the business to capture a preventive‑healthcare opportunity estimated at roughly $197 billion as it aims to become India’s largest integrated gastro‑metabolic platform. (smestreet.in)
